No registrations found.
ID
Source
Brief title
Health condition
Spinal cord injury, Biomarker
Ruggenmergschade, Biomerker
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary outcome of this study is to identify a panel of candidate biomarkers in spinal cord injury pathology.
Secondary outcome
The secondary outcome of this study is to characterize the identified candidate biomarkers for their relevance in spinal cord injury pathology.
Background summary
The goal of this study is to determine the antibody reactivity profile after spinal cord injury by using serological antigen selection. This will result in a panel of novel candidate antibody biomarkers that will be studied further for their pathogenic, prognostic and/or theranostic potential in spinal cord injury pathology.
Study objective
N/A
Study design
The predetermined time points for blood sampling are:
T0: at admission
T1: 3 weeks after injury
T2: 6 weeks after injury
T3: 12 weeks after injury
T4: 18 weeks after injury
Remark: Blood samples are only collected at standard blood tests.
Intervention
An additional tube of blood is collected during a standard blood test together with clinical information relevant for the study.
Hasselt University
Veerle Somers
Diepenbeek 3590
Belgium
+32 11269202
veerle.somers@uhasselt.be
Hasselt University
Veerle Somers
Diepenbeek 3590
Belgium
+32 11269202
veerle.somers@uhasselt.be
Inclusion criteria
All traumatic and pathological spinal cord injury patients can be included in this study (> 18 years both male and female).
Exclusion criteria
The exclusion criteria of this study is the presence of pre-existing autoimmune disorders.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL4052 |
| NTR-old | NTR4268 |
| Other | METC azM/UM : METC 13-4-079 |
| ISRCTN | ISRCTN wordt niet meer aangevraagd. |